The global market for Oral Direct Factor Xa Inhibitor was valued at US$ 2465 million in the year 2024 and is projected to reach a revised size of US$ 3539 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Oral Direct Factor Xa Inhibitor Market

Oral Direct Factor Xa Inhibitor is a type of medication that is taken orally (by mouth) and specifically designed to inhibit (block) the activity of Factor Xa, which is a key enzyme involved in the blood coagulation (clotting) process. By inhibiting Factor Xa, these inhibitors can effectively reduce the formation of blood clots, thereby lowering the risk of thromboembolic events (such as deep vein thrombosis and pulmonary embolism).

North American market for Oral Direct Factor Xa Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oral Direct Factor Xa Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Oral Direct Factor Xa Inhibitor in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Oral Direct Factor Xa Inhibitor include Bristol-Meyers Squibb Co, Pfizer, Boehringer Ingelheim Pharmaceuticals, Janssen Pharmaceuticals, Bayer AG, Teva Pharmaceutical Industries, Pab Organics Private Limited, Daiichi Sankyo Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oral Direct Factor Xa Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Direct Factor Xa Inhibitor.

The Oral Direct Factor Xa Inhibitor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Direct Factor Xa Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Direct Factor Xa Inhibitor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Direct Factor Xa Inhibitor Market Report

Report Metric	Details
Report Name	Oral Direct Factor Xa Inhibitor Market
Accounted market size in year	US$ 2465 million
Forecasted market size in 2031	US$ 3539 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Apixaban Dabigatran Rivaroxaban Edoxaban
Segment by Application	Hospitals Clinics Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Meyers Squibb Co, Pfizer, Boehringer Ingelheim Pharmaceuticals, Janssen Pharmaceuticals, Bayer AG, Teva Pharmaceutical Industries, Pab Organics Private Limited, Daiichi Sankyo Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Direct Factor Xa Inhibitor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Direct Factor Xa Inhibitor Market growing?

Ans: The Oral Direct Factor Xa Inhibitor Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Oral Direct Factor Xa Inhibitor Market size in 2031?

Ans: The Oral Direct Factor Xa Inhibitor Market size in 2031 will be US$ 3539 million.

Who are the main players in the Oral Direct Factor Xa Inhibitor Market report?

Ans: The main players in the Oral Direct Factor Xa Inhibitor Market are Bristol-Meyers Squibb Co, Pfizer, Boehringer Ingelheim Pharmaceuticals, Janssen Pharmaceuticals, Bayer AG, Teva Pharmaceutical Industries, Pab Organics Private Limited, Daiichi Sankyo Company

What are the Application segmentation covered in the Oral Direct Factor Xa Inhibitor Market report?

Ans: The Applications covered in the Oral Direct Factor Xa Inhibitor Market report are Hospitals, Clinics, Pharmacy

What are the Type segmentation covered in the Oral Direct Factor Xa Inhibitor Market report?

Ans: The Types covered in the Oral Direct Factor Xa Inhibitor Market report are Apixaban, Dabigatran, Rivaroxaban, Edoxaban

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Direct Factor Xa Inhibitor Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Apixaban

1.2.3 Dabigatran

1.2.4 Rivaroxaban

1.2.5 Edoxaban

1.3 Market by Application

1.3.1 Global Oral Direct Factor Xa Inhibitor Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Direct Factor Xa Inhibitor Market Perspective (2020-2031)

2.2 Global Oral Direct Factor Xa Inhibitor Growth Trends by Region

2.2.1 Global Oral Direct Factor Xa Inhibitor Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Direct Factor Xa Inhibitor Historic Market Size by Region (2020-2025)

2.2.3 Oral Direct Factor Xa Inhibitor Forecasted Market Size by Region (2026-2031)

2.3 Oral Direct Factor Xa Inhibitor Market Dynamics

2.3.1 Oral Direct Factor Xa Inhibitor Industry Trends

2.3.2 Oral Direct Factor Xa Inhibitor Market Drivers

2.3.3 Oral Direct Factor Xa Inhibitor Market Challenges

2.3.4 Oral Direct Factor Xa Inhibitor Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Direct Factor Xa Inhibitor Players by Revenue

3.1.1 Global Top Oral Direct Factor Xa Inhibitor Players by Revenue (2020-2025)

3.1.2 Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Players (2020-2025)

3.2 Global Top Oral Direct Factor Xa Inhibitor Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Direct Factor Xa Inhibitor Revenue

3.4 Global Oral Direct Factor Xa Inhibitor Market Concentration Ratio

3.4.1 Global Oral Direct Factor Xa Inhibitor Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Direct Factor Xa Inhibitor Revenue in 2024

3.5 Global Key Players of Oral Direct Factor Xa Inhibitor Head office and Area Served

3.6 Global Key Players of Oral Direct Factor Xa Inhibitor, Product and Application

3.7 Global Key Players of Oral Direct Factor Xa Inhibitor, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Direct Factor Xa Inhibitor Breakdown Data by Type

4.1 Global Oral Direct Factor Xa Inhibitor Historic Market Size by Type (2020-2025)

4.2 Global Oral Direct Factor Xa Inhibitor Forecasted Market Size by Type (2026-2031)

5 Oral Direct Factor Xa Inhibitor Breakdown Data by Application

5.1 Global Oral Direct Factor Xa Inhibitor Historic Market Size by Application (2020-2025)

5.2 Global Oral Direct Factor Xa Inhibitor Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Direct Factor Xa Inhibitor Market Size (2020-2031)

6.2 North America Oral Direct Factor Xa Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025)

6.4 North America Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Direct Factor Xa Inhibitor Market Size (2020-2031)

7.2 Europe Oral Direct Factor Xa Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025)

7.4 Europe Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Direct Factor Xa Inhibitor Market Size (2020-2031)

8.2 Asia-Pacific Oral Direct Factor Xa Inhibitor Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Direct Factor Xa Inhibitor Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Direct Factor Xa Inhibitor Market Size (2020-2031)

9.2 Latin America Oral Direct Factor Xa Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025)

9.4 Latin America Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size (2020-2031)

10.2 Middle East & Africa Oral Direct Factor Xa Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bristol-Meyers Squibb Co

11.1.1 Bristol-Meyers Squibb Co Company Details

11.1.2 Bristol-Meyers Squibb Co Business Overview

11.1.3 Bristol-Meyers Squibb Co Oral Direct Factor Xa Inhibitor Introduction

11.1.4 Bristol-Meyers Squibb Co Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.1.5 Bristol-Meyers Squibb Co Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Oral Direct Factor Xa Inhibitor Introduction

11.2.4 Pfizer Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Boehringer Ingelheim Pharmaceuticals

11.3.1 Boehringer Ingelheim Pharmaceuticals Company Details

11.3.2 Boehringer Ingelheim Pharmaceuticals Business Overview

11.3.3 Boehringer Ingelheim Pharmaceuticals Oral Direct Factor Xa Inhibitor Introduction

11.3.4 Boehringer Ingelheim Pharmaceuticals Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.3.5 Boehringer Ingelheim Pharmaceuticals Recent Development

11.4 Janssen Pharmaceuticals

11.4.1 Janssen Pharmaceuticals Company Details

11.4.2 Janssen Pharmaceuticals Business Overview

11.4.3 Janssen Pharmaceuticals Oral Direct Factor Xa Inhibitor Introduction

11.4.4 Janssen Pharmaceuticals Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.4.5 Janssen Pharmaceuticals Recent Development

11.5 Bayer AG

11.5.1 Bayer AG Company Details

11.5.2 Bayer AG Business Overview

11.5.3 Bayer AG Oral Direct Factor Xa Inhibitor Introduction

11.5.4 Bayer AG Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.5.5 Bayer AG Recent Development

11.6 Teva Pharmaceutical Industries

11.6.1 Teva Pharmaceutical Industries Company Details

11.6.2 Teva Pharmaceutical Industries Business Overview

11.6.3 Teva Pharmaceutical Industries Oral Direct Factor Xa Inhibitor Introduction

11.6.4 Teva Pharmaceutical Industries Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.6.5 Teva Pharmaceutical Industries Recent Development

11.7 Pab Organics Private Limited

11.7.1 Pab Organics Private Limited Company Details

11.7.2 Pab Organics Private Limited Business Overview

11.7.3 Pab Organics Private Limited Oral Direct Factor Xa Inhibitor Introduction

11.7.4 Pab Organics Private Limited Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.7.5 Pab Organics Private Limited Recent Development

11.8 Daiichi Sankyo Company

11.8.1 Daiichi Sankyo Company Company Details

11.8.2 Daiichi Sankyo Company Business Overview

11.8.3 Daiichi Sankyo Company Oral Direct Factor Xa Inhibitor Introduction

11.8.4 Daiichi Sankyo Company Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025)

11.8.5 Daiichi Sankyo Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bristol-Meyers Squibb Co

Pfizer Inc

Boehringer Ingelheim Pharmaceuticals

Janssen Pharmaceuticals

Bayer

Teva Pharmaceutical Industries

Pab Organics Private Limited

Daiichi Sankyo Company

List of Tables

Table 1. Global Oral Direct Factor Xa Inhibitor Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Apixaban

Table 3. Key Players of Dabigatran

Table 4. Key Players of Rivaroxaban

Table 5. Key Players of Edoxaban

Table 6. Global Oral Direct Factor Xa Inhibitor Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral Direct Factor Xa Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Oral Direct Factor Xa Inhibitor Market Share by Region (2020-2025)

Table 10. Global Oral Direct Factor Xa Inhibitor Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Oral Direct Factor Xa Inhibitor Market Share by Region (2026-2031)

Table 12. Oral Direct Factor Xa Inhibitor Market Trends

Table 13. Oral Direct Factor Xa Inhibitor Market Drivers

Table 14. Oral Direct Factor Xa Inhibitor Market Challenges

Table 15. Oral Direct Factor Xa Inhibitor Market Restraints

Table 16. Global Oral Direct Factor Xa Inhibitor Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Oral Direct Factor Xa Inhibitor Market Share by Players (2020-2025)

Table 18. Global Top Oral Direct Factor Xa Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Direct Factor Xa Inhibitor as of 2024)

Table 19. Ranking of Global Top Oral Direct Factor Xa Inhibitor Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Oral Direct Factor Xa Inhibitor Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Oral Direct Factor Xa Inhibitor, Headquarters and Area Served

Table 22. Global Key Players of Oral Direct Factor Xa Inhibitor, Product and Application

Table 23. Global Key Players of Oral Direct Factor Xa Inhibitor, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Oral Direct Factor Xa Inhibitor Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Type (2020-2025)

Table 27. Global Oral Direct Factor Xa Inhibitor Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Type (2026-2031)

Table 29. Global Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Application (2020-2025)

Table 31. Global Oral Direct Factor Xa Inhibitor Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Oral Direct Factor Xa Inhibitor Revenue Market Share by Application (2026-2031)

Table 33. North America Oral Direct Factor Xa Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Oral Direct Factor Xa Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Oral Direct Factor Xa Inhibitor Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Oral Direct Factor Xa Inhibitor Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Oral Direct Factor Xa Inhibitor Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Oral Direct Factor Xa Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bristol-Meyers Squibb Co Company Details

Table 49. Bristol-Meyers Squibb Co Business Overview

Table 50. Bristol-Meyers Squibb Co Oral Direct Factor Xa Inhibitor Product

Table 51. Bristol-Meyers Squibb Co Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 52. Bristol-Meyers Squibb Co Recent Development

Table 53. Pfizer Company Details

Table 54. Pfizer Business Overview

Table 55. Pfizer Oral Direct Factor Xa Inhibitor Product

Table 56. Pfizer Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 57. Pfizer Recent Development

Table 58. Boehringer Ingelheim Pharmaceuticals Company Details

Table 59. Boehringer Ingelheim Pharmaceuticals Business Overview

Table 60. Boehringer Ingelheim Pharmaceuticals Oral Direct Factor Xa Inhibitor Product

Table 61. Boehringer Ingelheim Pharmaceuticals Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 62. Boehringer Ingelheim Pharmaceuticals Recent Development

Table 63. Janssen Pharmaceuticals Company Details

Table 64. Janssen Pharmaceuticals Business Overview

Table 65. Janssen Pharmaceuticals Oral Direct Factor Xa Inhibitor Product

Table 66. Janssen Pharmaceuticals Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 67. Janssen Pharmaceuticals Recent Development

Table 68. Bayer AG Company Details

Table 69. Bayer AG Business Overview

Table 70. Bayer AG Oral Direct Factor Xa Inhibitor Product

Table 71. Bayer AG Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 72. Bayer AG Recent Development

Table 73. Teva Pharmaceutical Industries Company Details

Table 74. Teva Pharmaceutical Industries Business Overview

Table 75. Teva Pharmaceutical Industries Oral Direct Factor Xa Inhibitor Product

Table 76. Teva Pharmaceutical Industries Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 77. Teva Pharmaceutical Industries Recent Development

Table 78. Pab Organics Private Limited Company Details

Table 79. Pab Organics Private Limited Business Overview

Table 80. Pab Organics Private Limited Oral Direct Factor Xa Inhibitor Product

Table 81. Pab Organics Private Limited Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 82. Pab Organics Private Limited Recent Development

Table 83. Daiichi Sankyo Company Company Details

Table 84. Daiichi Sankyo Company Business Overview

Table 85. Daiichi Sankyo Company Oral Direct Factor Xa Inhibitor Product

Table 86. Daiichi Sankyo Company Revenue in Oral Direct Factor Xa Inhibitor Business (2020-2025) & (US$ Million)

Table 87. Daiichi Sankyo Company Recent Development

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Oral Direct Factor Xa Inhibitor Picture

Figure 2. Global Oral Direct Factor Xa Inhibitor Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Direct Factor Xa Inhibitor Market Share by Type: 2024 VS 2031

Figure 4. Apixaban Features

Figure 5. Dabigatran Features

Figure 6. Rivaroxaban Features

Figure 7. Edoxaban Features

Figure 8. Global Oral Direct Factor Xa Inhibitor Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Oral Direct Factor Xa Inhibitor Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Pharmacy Case Studies

Figure 13. Oral Direct Factor Xa Inhibitor Report Years Considered

Figure 14. Global Oral Direct Factor Xa Inhibitor Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Oral Direct Factor Xa Inhibitor Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Oral Direct Factor Xa Inhibitor Market Share by Region: 2024 VS 2031

Figure 17. Global Oral Direct Factor Xa Inhibitor Market Share by Players in 2024

Figure 18. Global Oral Direct Factor Xa Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Oral Direct Factor Xa Inhibitor Revenue in 2024

Figure 20. North America Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Oral Direct Factor Xa Inhibitor Market Share by Country (2020-2031)

Figure 22. United States Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oral Direct Factor Xa Inhibitor Market Share by Country (2020-2031)

Figure 26. Germany Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oral Direct Factor Xa Inhibitor Market Share by Region (2020-2031)

Figure 34. China Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oral Direct Factor Xa Inhibitor Market Share by Country (2020-2031)

Figure 42. Mexico Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oral Direct Factor Xa Inhibitor Market Share by Country (2020-2031)

Figure 46. Turkey Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Oral Direct Factor Xa Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Bristol-Meyers Squibb Co Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 51. Boehringer Ingelheim Pharmaceuticals Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 52. Janssen Pharmaceuticals Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 53. Bayer AG Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 54. Teva Pharmaceutical Industries Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 55. Pab Organics Private Limited Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 56. Daiichi Sankyo Company Revenue Growth Rate in Oral Direct Factor Xa Inhibitor Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions